# Clinical Safety of a Novel Milk Protein Peptide

> **NCT01412658** · PHASE1 · COMPLETED · sponsor: **Ambryx Biotechnology** · enrollment: 73 (actual)

## Conditions studied

- Drug Safety

## Interventions

- **DIETARY_SUPPLEMENT:** Hydrolyzed milk protein mixture
- **DIETARY_SUPPLEMENT:** Glycerol placebo

## Key facts

- **NCT ID:** NCT01412658
- **Lead sponsor:** Ambryx Biotechnology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-01
- **Final completion:** 2007-02
- **Target enrollment:** 73 (ACTUAL)
- **Last updated:** 2011-08-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01412658

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01412658, "Clinical Safety of a Novel Milk Protein Peptide". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01412658. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*